Izun Pharmaceuticals
New York, United States· Est.
Botanical‑based therapeutics for oral, wound, women's health, and oncology support.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Botanical‑based therapeutics for oral, wound, women's health, and oncology support.
Oral healthWomen's healthWound healingOncology supportive care
Technology Platform
Proprietary plant extraction and analytics that preserve synergistic phytochemicals while ensuring safety and regulatory compliance.
Opportunities
Expanding into large, underserved markets such as GSM and chronic wound care, and leveraging FDA‑cleared botanical products to secure payer coverage and global distribution.
Risk Factors
Regulatory hurdles for botanical drugs, competition from synthetic alternatives, and the need for significant capital to advance late‑stage clinical programs.
Competitive Landscape
Competes with both traditional synthetic therapeutics and nutraceutical firms; differentiation stems from patented extraction technology, FDA clearance, and a focus on synergistic multi‑component botanicals.